Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | OBP-301 + Radiotherapy |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| OBP-301 | OBP301|OBP 301|Telomelysin|Telomelycin|Suratadenoturev | OBP-301 (telomelysin) is an oncolytic adenovirus that may increase tumor cell lysis and radiosensitivity (J Clin Onc 2019 37:4_suppl, 130). | ||
| Radiotherapy |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|